Furthermore, in the Tim3+PD-1+ CD8 T cells, two inhibitory molecules, TIGIT- and LAG3- double-positive cells were increased by myeloma transplantation and the increment was cancelled by cDC1 depletion (Figure 4A). This evidence concerns the gene HAVCR2 and plasma cell myeloma.